CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:PD-1 signaling and PD-1 blockade-mediated tumor control are established at microvillar T cell contacts.
PD-1 signaling and PD-1 blockade-mediated tumor control are established at microvillar T cell contacts.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
淋巴细胞活化依赖于细胞间接触处多种受体信号的整合,但这一过程的时空调控尚不清楚。在此,我们发现程序性细胞死亡蛋白1(PD-1)和T细胞受体(TCR)信号在T细胞与其靶细胞相互作用过程中形成的纳米级微绒毛紧密接触处进行整合。PD-1信号在这些接触形成时即启动,并选择性限制TCR信号的持续时间,但不影响其幅度。PD-1通过局部招募含Src同源2结构域的蛋白酪氨酸磷酸酶-2(SHP2)直接抑制TCR活性,并通过减少细胞铺展、紧密接触形成和TCR结合间接抑制TCR活性。当Fc受体结合将PD-1捕获在紧密接触处时,PD-1阻断抗体反而诱导了抑制性信号。通过对抗体进行工程改造以防止PD-1被捕获,消除了这些激动效应并提高了阻断疗效。这些发现确定了微绒毛接触是初始信号整合的关键枢纽,并为优化检查点免疫治疗提供了框架。
Lymphocyte activation relies on the integration of signals from multiple receptors at cell-cell contacts, but the spatiotemporal regulation of this process is unclear.
Here, we show that programmed cell death protein 1 (PD-1) and T cell receptor (TCR) signals are integrated at nanoscale microvillar close contacts formed during T cell interactions with their targets. PD-1 signaling begins as these contacts form and selectively limits the duration, but not the amplitude, of TCR signaling.
PD-1 suppresses TCR activity directly, by locally recruiting Src homology 2 domain-containing protein tyrosine phosphatase-2 (SHP2), and indirectly, by reducing cell-spreading, close-contact formation, and TCR engagement. A PD-1 blocking antibody induced inhibitory signaling when Fc receptor engagement trapped PD-1 at close contacts. Engineering the antibody to prevent PD-1 trapping eliminated these agonistic effects and improved blockade efficacy.
These findings identify microvillar contacts as crucial hubs of initial signal integration and provide a framework for optimizing checkpoint immunotherapies.
MEMBER ACCOUNT
登录成功会直接打开下一页。